Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Caugant

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Current Microbiology|November 24, 1999
Genome stability of Bacillus thuringiensis subsp. israelensis isolatesJ Ankarloo, D A Caugant, B M Hansen, et al.
Journal of Medical Microbiology|May 1, 1991
An epidemiologically valuable typing method for Neisseria meningitidis by analysis of restriction fragment length polymorphismsA J Fox, D M Jones, S J Gray, et al.
Epidemiology and Infection|April 1, 1996
Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94M Guibourdenche, E A Høiby, J Y Riou, et al.
Journal of Clinical Microbiology|May 6, 2005
Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in NorwayP Littauer, M Sangvik, D A Caugant, et al.
Scandinavian Journal of Immunology|April 28, 2012
An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis beltG Norheim, G Tunheim, L M Næss, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinantsP Littauer, D A Caugant, M Sangvik, et al.
Infection and Immunity|July 1, 1986
Difference in structure between type b and nontypable Haemophilus influenzae populationsO Porras, D A Caugant, B Gray, et al.
Journal of Clinical Microbiology|November 1, 1991
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in CanadaF E Ashton, J A Ryan, A Borczyk, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2004
Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999O S Toungoussova, N I Nizovtseva, A O Mariandyshev, et al.
Microbiology (Reading, England)|July 1, 1995
A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccineA A Delvig, E Wedege, D A Caugant, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Current Microbiology|November 24, 1999
Genome stability of Bacillus thuringiensis subsp. israelensis isolatesJ Ankarloo, D A Caugant, B M Hansen, et al.
Journal of Medical Microbiology|May 1, 1991
An epidemiologically valuable typing method for Neisseria meningitidis by analysis of restriction fragment length polymorphismsA J Fox, D M Jones, S J Gray, et al.
Epidemiology and Infection|April 1, 1996
Epidemics of serogroup A Neisseria meningitidis of subgroup III in Africa, 1989-94M Guibourdenche, E A Høiby, J Y Riou, et al.
Journal of Clinical Microbiology|May 6, 2005
Molecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in NorwayP Littauer, M Sangvik, D A Caugant, et al.
Scandinavian Journal of Immunology|April 28, 2012
An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis beltG Norheim, G Tunheim, L M Næss, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2006
Macrolide-resistant Streptococcus pyogenes in Norway: population structure and resistance determinantsP Littauer, D A Caugant, M Sangvik, et al.
Infection and Immunity|July 1, 1986
Difference in structure between type b and nontypable Haemophilus influenzae populationsO Porras, D A Caugant, B Gray, et al.
Journal of Clinical Microbiology|November 1, 1991
Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in CanadaF E Ashton, J A Ryan, A Borczyk, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 22, 2004
Impact of drug-resistant Mycobacterium tuberculosis on treatment outcome of culture-positive cases of tuberculosis in the Archangel oblast, Russia, in 1999O S Toungoussova, N I Nizovtseva, A O Mariandyshev, et al.
Microbiology (Reading, England)|July 1, 1995
A linear B-cell epitope on the class 3 outer-membrane protein of Neisseria meningitidis recognized after vaccination with the Norwegian group B outer-membrane vesicle vaccineA A Delvig, E Wedege, D A Caugant, et al.
Pageof 13